Recent Posts

FDA approves first non-antipsychotic drug for Alzheimer’s agitation

NEWYou can now listen to Fox News articles! The U.S. Food and Drug Administration has green-lit the first-ever non-antipsychotic drug treatment for agitation in Alzheimer’s disease patients. The drug, Auvelity, was originally FDA-approved in 2022 for treating adults with major depressive disorder. Most recently, its use has been expanded for …

Read More »
The Ultimate Managed Hosting Platform